Clinical trial Recruiting at 1 site Observational

Registry for patients with ASXL-related disorders

Official title: Natural History Study for the ASXL-Related Disorders and Chromatinopathies

Run by University of California, Los Angeles · NCT03303716 · Data updated 2026-11-12

This study is collecting information from patients with Bohring-Opitz, Shashi-Pena, and Bainbridge-Ropers Syndromes to learn more about their conditions and how to manage them better.

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedSeptember 20, 2017
Main results expectedSeptember 2037
Study endsSeptember 2037
Registry record updatedDecember 26, 2025
Trial IDNCT03303716 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a clinical or molecular diagnosis of an ASXL-related disorder.

Probably not a fit

Patients without a clinical or molecular diagnosis of an ASXL-related disorder will not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry focuses on the natural history, management, and treatment of patients diagnosed with Bohring-Opitz Syndrome, Shashi-Pena Syndrome, and Bainbridge-Ropers Syndrome. Participants will complete a series of surveys over time regarding their medical conditions, and researchers will collect primary medical records. The study is conducted in collaboration with several prominent children's hospitals and is supported by non-profit organizations dedicated to ASXL-related disorders. Data will be shared with participants and used for research publications while ensuring HIPAA compliance.

Why it matters

Potential benefit: If successful, this registry could enhance understanding and management of ASXL-related disorders, leading to improved patient care.

How similar studies have gone: Other studies focusing on rare genetic disorders have shown success in improving patient outcomes through registry data collection.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical or molecular diagnosis of an ASXL related disorder

Exclusion Criteria:

* No clinical or molecular diagnosis of an ASXL related disorder

Where it's running

  • University of California, Los Angeles
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.